Table 4.
Study | SSEa | Ratio of SSE for current model compared with Salazar et al. (2015)b | |
---|---|---|---|
ETBE‐TBA model presented | Salazar et al. (2015) | ||
TBA IV (Poet et al., 1997) | 1.24E + 06 | 3.89E + 06 | 0.3 |
TBA inhalation (Leavens & Borghoff, 2009); includes both single and repeat | 7.14E + 04 | 7.74E + 04 | 0.9 |
TBA gavage (ARCO, 1983; unpublished report); blood | 3.71E + 05 | 1.36E + 05 | 2.7 |
TBA gavage (ARCO, 1983; unpublished report); urinary excretion percentage | 5.27E + 03 | 8.26E + 03 | 0.6 |
TBA blood concentrations following ETBE gavage (JPEC, 2008b; single) | 6.42E + 01 | 2.17E + 03 | 0.03 |
TBA blood concentrations following ETBE gavage (JPEC, 2008c; repeated) | 3.17E+00c | 2.3E+00c | 1.4 |
TBA cumulative in urine following ETBE gavage (JPEC, 2008b; single) | 2.22E + 01 | 1.13E‐01d | 2.0E2 |
Percentage dose exhaled versus excreted following ETBE gavage (JPEC, 2008b; single) | 9.94E + 01 | 2.85E + 04 | 0.004 |
ETBE blood concentrations following ETBE inhalation study (Amberg et al., 2000) | 1.25E + 00 | 3.45E‐01 | 3.6 |
TBA blood concentrations following ETBE inhalation study (Amberg et al., 2000) | 7.11E‐01 | 3.40E + 00 | 0.2 |
Percentage dose excreted following ETBE inhalation study (Amberg et al., 2000) | 2.41E + 01 | 1.45E + 02 | 0.2 |
Cumulative TBA in urine following ETBE inhalation study (Amberg et al., 2000) | 7.65E‐05 | 8.22E‐03 | 0.01 |
ETBE, ethyl tertiary‐butyl ether; TBA, tertiary‐butyl alcohol.
Estimated from square of difference between predicted value and observed data for study.
Ratios less than one indicate a better prediction of data with current model and are shaded for emphasis.
Fits for both models are improved if no induction is assumed for TBA metabolism.
Note that the TBA urine was closer to the measured because of lower urinary elimination, which results in TBA blood concentrations with a larger discrepancy compared to measured values.